(Q39727219)

14 September 2017

Mortality in an urban cohort of HIV-infected and at-risk drug users in the era of highly active antiretroviral therapy (English)

1 reference

14 September 2017

0 references

anti-retroviral agent

0 references

author name string

Rakhi Kohli

1

1 reference

14 September 2017

Yungtai Lo

2

1 reference

14 September 2017

Andrea A Howard

3

1 reference

14 September 2017

Donna Buono

4

1 reference

14 September 2017

Michelle Floris-Moore

5

1 reference

14 September 2017

Robert S Klein

6

1 reference

14 September 2017

Ellie E Schoenbaum

7

1 reference

14 September 2017

language of work or name

English

0 references

publication date

16 August 2005

1 reference

Clinical Infectious Diseases

14 September 2017

1 reference

14 September 2017

41

1 reference

14 September 2017

6

1 reference

14 September 2017

864-872

1 reference

Natural history of HIV infection in the era of combination antiretroviral therapy

14 September 2017

1 reference

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

21 January 2018

1 reference

Self-reported antiretroviral therapy in injection drug users.

21 January 2018

1 reference

Variations in the care of HIV-infected adults in the United States: results from the HIV Cost and Services Utilization Study

21 January 2018

1 reference

Barriers to use of free antiretroviral therapy in injection drug users.

21 January 2018

1 reference

Racial and gender disparities in receipt of highly active antiretroviral therapy persist in a multistate sample of HIV patients in 2001.

21 January 2018

1 reference

Limited effect of highly active antiretroviral therapy among HIV-positive injecting drug users on the population level

21 January 2018

1 reference

Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users.

21 January 2018

1 reference

Mortality rates and causes of death in a cohort of HIV-infected and uninfected women, 1993-1999.

21 January 2018

1 reference

Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection

21 January 2018

1 reference

Risk factors for human immunodeficiency virus infection in intravenous drug users

21 January 2018

1 reference

Changing patterns in causes of death in a cohort of injecting drug users, 1980-2001.

21 January 2018

1 reference

Pre-AIDS mortality from natural causes associated with HIV disease progression: evidence from the European Seroconverter Study among injecting drug users

21 January 2018

1 reference

Gender and clinical outcomes after starting highly active antiretroviral treatment: a cohort study

21 January 2018

1 reference

Gender and hospitalization patterns among HIV-infected drug users before and after the availability of highly active antiretroviral therapy.

21 January 2018

1 reference

Decline in the AIDS and death rates in the EuroSIDA study: an observational study

21 January 2018

1 reference

Impact of HIV infection on mortality in a cohort of injection drug users

21 January 2018

1 reference

Mortality in HIV-seropositive versus -seronegative persons in the era of highly active antiretroviral therapy: implications for when to initiate therapy

21 January 2018

1 reference

Longitudinal Patterns of Drug Injection Behavior in the ALIVE Study Cohort,1988-2000: Description and Determinants

21 January 2018

1 reference

Effect of hard-drug use on CD4 cell percentage, HIV RNA level, and progression to AIDS-defining class C events among HIV-infected women

21 January 2018

1 reference

Antiretroviral therapy, hepatitis C virus, and AIDS mortality among San Francisco's homeless and marginally housed

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/432883

1 reference

14 September 2017

1 reference